API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu
https://www.fiercepharma.com/pharma/republican-lawmakers-slap-fda-probe-drug-shortage-oversight
https://www.globenewswire.com//news-release/2023/10/30/2769171/0/en/Phathom-Pharmaceuticals-Announces-FDA-Approval-of-Reformulated-Vonoprazan-Tablets-for-VOQUEZNA-TRIPLE-PAK-vonoprazan-amoxicillin-clarithromycin-and-VOQUEZNA-DUAL-PAK-vonoprazan-amo.html
https://www.francetvinfo.fr/replay-radio/l-interview-eco/penurie-de-medicaments-le-gouvernement-a-compris-qu-il-y-avait-un-lien-entre-le-prix-la-rentabilite-et-la-disponibilite-selon-jerome-wirotius-directeur-general-du-laboratoire-biogaran_6036089.html
https://www.fiercepharma.com/pharma/republican-governors-call-congress-resolve-spate-us-drug-shortages
https://www.centrient.com/media/ginkgo-bioworks-and-centrient-pharmaceuticals-announce-expansion-partnership-following
https://www.fiercepharma.com/pharma/tamiflu-supplies-take-hit-latest-chapter-2022s-us-drug-shortage-saga
https://www.centrient.com/media/centrient-celebrates-14th-birthday-aguila-project-completion-and-first-enzymatically-produced
https://endpts.com/fdas-drug-shortages-leader-wants-companies-to-start-reporting-increases-in-demand/
https://www.bloomberg.com/news/newsletters/2022-11-02/amoxicillin-shortage-reveals-fragility-of-antibiotic-supply
https://www.nbcnews.com/science/science-news/pharmacies-are-reporting-shortages-widely-used-antibiotic-amoxicillin-rcna53476
https://www.prnewswire.com/news-releases/redhill-biopharma-presents-new-talicia-and-movantik-data-analyses-at-acg-2021-301407403.html
https://www.globenewswire.com/news-release/2021/09/08/2293340/0/en/Phathom-Pharmaceuticals-Submits-Two-NDAs-to-U-S-FDA-for-Vonoprazan-based-Treatment-Regimens-for-the-Treatment-of-H-pylori-Infection.html
https://psnc.org.uk/our-news/class-4-medicines-defect-information-amoxicillin-500mg-5ml-powder-for-oral-suspension/
https://www.fiercepharma.com/manufacturing/glaxosmithkline-could-cut-up-to-60-workers-at-uk-site-as-it-ends-production
https://www.globenewswire.com/news-release/2020/07/27/2067800/0/en/RedHill-Biopharma-Increases-Patient-Access-to-Talicia-with-EnvisionRx-Formularies.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205274
https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=15262
https://www.moneycontrol.com/news/india/coronavirus-outbreak-govt-panel-lists-essential-medicines-that-may-run-out-of-stock-report-4994821.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.globenewswire.com/news-release/2019/02/19/1733960/0/en/The-Delhi-High-Court-in-India-has-issued-an-injunction-restraining-Sinopharm-Weiqida-from-exporting-its-Amoxycillin-Trihydrate-product-to-India-as-it-infringes-the-patent-of-Centri.html
https://endpts.com/with-looming-superbug-crisis-iterum-misses-in-a-key-antibiotic-trial-and-its-shares-tumble/
https://www.raps.org/news-and-articles/news-articles/2019/10/fda-warns-california-drug-distributor-for-listing
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/antibiotic-resistance-in-food-animals-growing/articleshow/71213015.cms
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-zoetis-clavamox-drops-1559804353.pdf
https://www.pharmacompass.com/pdf/news/class-2-medicines-recall-co-amoxiclav-125-mg3125-mg5-ml-and-25-mg625-mg5-ml-powder-for-oral-suspension-1557816369.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209371
https://www.globenewswire.com/news-release/2019/02/19/1733960/0/en/The-Delhi-High-Court-in-India-has-issued-an-injunction-restraining-Sinopharm-Weiqida-from-exporting-its-Amoxycillin-Trihydrate-product-to-India-as-it-infringes-the-patent-of-Centri.html
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pharmasciences-pms-amoxicillin-1544006117.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-teva-canadas-novamoxin-granules-1543564458.pdf
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm626328.pdf
https://www.fiercepharma.com/manufacturing/dr-reddy-s-unloads-antibiotics-plant-to-abu-dhabi-based-neopharma
https://www.fiercepharma.com/manufacturing/ema-bans-antibiotic-apis-produced-by-producer-mongolia
https://www.in-pharmatechnologist.com/Article/2017/10/09/DSP-accuses-CSPC-of-amoxicillin-patent-infringement
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2017-1504668920.pdf
https://globenewswire.com/news-release/2017/08/17/1087023/0/en/RedHill-Biopharma-Announces-U-S-Commercialization-Agreement-for-FDA-Approved-GI-Product-Esomeprazole-Strontium-Delayed-Release-Capsules.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2017-1496811142.pdf
http://www.prnewswire.com/news-releases/dsm-sinochem-pharmaceuticals-wins-indian-patent-infringement-case-against-sinopharm-weiqida-pharmaceutical-300461850.html
http://www.prnewswire.com/news-releases/dsm-sinochem-pharmaceuticals-announces-licensing-agreement-for-intellectual-property-assets-related-to-the-manufacture-of-beta-lactam-antibiotics-300425551.html
http://www.in-pharmatechnologist.com/Ingredients/DSM-Sinochem-licenses-antibiotic-tech-to-Sandoz-sues-Weiqida
http://www.newindianexpress.com/business/2017/feb/23/634-drugs-suspected-to-be-not-compliant-with-government-price-ceiling-1574027.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205707